Planned scientific outputs

ECDC is committed to maintaining transparency and to this end, publishes a list of scientific outputs in planning. The list is updated weekly and spans a 12-month rolling period, encompassing both the preceding three months and the forthcoming nine months.

It is important to note that the list is not exhaustive and may be subject to change. Operational factors such as shifting priorities, resource allocation, and changes in stakeholder requests can influence the continuation or discontinuation of planned outputs. Moreover, the list does not include outputs related to assessments, which are typically produced in response to immediate risks or unexpected events.

Should you have any inquiries or feedback, do not hesitate to reach out at ecdc.info@ecdc.europa.eu.

134 results found Export 134 results to CSV

The "Category" and "Status" values in the table below are explained in more detail here.


Page last updated: 20 July 2025

Surveillance and monitoring

Country visit report: ECDC/EC/EFSA country visit to Serbia to advance One Health responses against antimicrobial resistance (AMR)

Surveillance and monitoring

COVID-19 vaccination coverage in the EU/EEA during the 2024-25 season campaigns. Data period under analysis: 1 August 2024 to 28 March 2025.

Surveillance and monitoring

COVID-19 vaccine effectiveness against hospitalisation in older adults, VEBIS hospital network, Europe, September 2024 May 2025

Surveillance and monitoring

COVID-19 vaccine effectiveness against hospitalisation in older adults, VEBIS hospital network, Europe, September 2024-March 2025

Cross-border investigation of a tuberculosis Cluster ( ST215- Beijing 2.2.1) affecting migrants in the EU/EEA

Cross-border spread of a mosaic resistance (OXA-48) and virulence (aerobactin) plasmid in Klebsiella pneumoniae: a European Antimicrobial Resistance Genes Surveillance Network investigation, Europe, February 2019 to October 2024

Surveillance and monitoring

Deferral criteria and testing strategies for dengue virus in blood donors within the EU/EEA

Surveillance and monitoring

Deferral criteria and testing strategies for dengue virus in blood donors within the EU/EEA

Doubling of Legionnaires' disease surveillance notifications rate in EU/EEA under recent decade

Public health guidance

DoxyPEP - considerations for EU/EEA